Skip to main content
. Author manuscript; available in PMC: 2016 Feb 2.
Published in final edited form as: Immunobiology. 2009 Jan 20;214(7):495–505. doi: 10.1016/j.imbio.2008.11.006

Fig. 7.

Fig. 7

MHC-II surface transport is delayed in Syt VII-deficient cells. (A) Immature Syt VII+/+ or Syt VII−/− DCs were stimulated with LPS and cluster disruption and assessed for MHC-II and CD86 surface expression by FACS at indicated time points up to 12 h. Top profiles compare MHC-II levels, and bottom profiles compare CD86 levels. Syt VII+/+ DCs (blue), Syt VII−/− DCs (red). For clarity, the isotype control antibody pattern is only shown for the 12 h time point (right panels, grey). (B) Quantification of the geometric mean fluorescence of the charts shown in A. The results shown are representative of three independent experiments.

HHS Vulnerability Disclosure